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Introduction: 
Rubella is a disease caused by the rubella virus and it is usually mild and self-limiting. Infection 
of a developing fetus is serious and important because the child may be born with congenital 
rubella syndrome. Its symptoms include mental retardation, heart defects, cataract, etc. 
In 2003, mass vaccination against measles and rubella in individuals 5-25 years old was done. 
One of the main objectives of this study was to survey congenital rubella infection status with the 
presence of IgM antibodies against rubella virus in cord blood samples and also the immunity 
assessment of maternal IgG antibodies against rubella virus in the above samples. 
  
Methods: 
The cross-sectional study was to determine the transfer of congenital rubella in 358 cord blood 
samples collected in hospitals affiliated to the Tehran University of Medical  
Sciences that was done in 2008-2009 
  
The collected samples were analyzed by two ELISA methods for detection of IgG and IgM 
antibodies, RT-Nested PCR tests was applied on samples of IgG–negative and IgM-positive and 
also some of randomly IgG-positive samples for identifying the presence of the virus genome. 
  
In this study two groups of mothers were tested, one consisted above 29 years of age (at the time 
of vaccination) with the frequency of 73.4% and the other one below 29 years of age with the 
frequency of 26.6%. 
  
Results: 
Of the 358 samples, 91.1% IgG and 2.8% were found to be positive. None of the 31 samples 
were positive according to the presence of the virus genome via the method of RT-Nested PCR. 
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Conclusion: 
According to high immunity of mothers, the probability of congenital rubella transmission was 
low, but because of low immunity of mothers of >29 years of age, it is much better to upgrade 
the age of vaccination to 28 years old. 
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Introduction: 
Rubella is a viral disease which is coused by a member of Rubivirus genus of the Togavirus 
family. Rubella virus etiologic agent is gezantomy mild disease with low fever, 
lymphadenopathy and short term of morbiliform rash. Rubella virus is the cause of congenital 
rubella syndrome and congenital abnormalities when infection occurs during pregnancy for the 
fetus.The most common complications of congenital rubella syndrome are as follows: 
1-Transient conclusions include low birth weight, thrombocytopenia, and hepatosplenomegaly, 
jaundice, pneumonia, and bone lesions, menengoencephalitis (stable or complications). 
2-Permanent conclusions including cataract, retinopathy, deafness, glaucoma, and microcephaly. 
3-Developmental conclusions which includ diabetes mellitus, mental backwardness, and disorder 
and sympathy.  
Multiple complications due to congenital rubella syndrome will impose heavy economical, 
emotional or social burden on families and societies. The importance of the matter will be more 
significant when percentage of disabled babies born whose complications are heavy and 
irreparable. But this problem can be resolved by the exact evaluation of women's immunity in 
childbearing age, therefore, the risk of exposure to congenital rubella syndrome can be assessed 
and non-immune (equivocal) women will be protected from CRS via vaccine-injection. 
Diagnosis of CRS cannot be based on symptoms in a newborn baby. This operation requires 
virus isolation or serological testing in an infant. In countries where vaccination is not done or in 
the early stages, consideration of CRS is very important. Diagnosis of rubella after birth and 
congenital infection rubella specific IgM by studying via EIA are carried out with commercial 
kits. Considering that these antibodies do not have the ability to cross the placenta, and fetus is 
capable of producing these antibodies therefore these antibodies indicate presence of fetal 
intrauterine infection. IgM is usually recognizable in congenital infection for one year. In 
countries where vaccination is carried out for long term, positive-IgM rate is decreased and risk 
of false positive is increased. 
  
Methods of study 
The descriptive / cross-sectional study was done on 358 collected cord blood samples of 
newborn babies in hospitals affiliated to Iran University of Medical Sciences in 2004-2005. The 
necessary information for the specifications of mothers and neonates was filled out by the 
questionnaire. 
The cord blood samples were collected in sterilized tube and immediately after blood 
coagulation, their serum was isolated by centrifugation. All samples were kept in the fridge at 
 -20 C0 until used. 
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ELISA test: ELISA kit (VIR-ELISA) made in Germany was used for qualitative and quantitative 
analysis of rubella virus specific IgM and IgG in serum and plasma samples. 
Extraction of RNA: RNA extraction kit using the High Pure Viral Nucleic Acid kit (Roche in 
Germany) was used in accordance with manufacturer instructions.  
 
Synthesis of cDNA: cDNA synthesis was performed using RT mix from Construction Company 
Bioneer. In this method, 5 micro liters of RNA extracted was added to the tube and then heated 
for an hour at 42 ° and followed by heat at 700 for 5 min to inactivate RT. 
Nested PCR test for diagnosis of rubella:  
The test consisted of two phases PCR (PCR1, PCR2). Using two primers, R2 and R7 to R11 and 
R8C for PCR1 and  for PCR2. Primers R2 and R7 outer primers and 185 bp region of the 
genome were used Rubella E1 part too .(Table1) 
 
 
 
 
Table1: Primers used in Nested PCR Reaction  
Primers used in PCR1 
Name Forward Reverse 
R2/R7 CAA CAC GCC GCA CGG ACA AC CCA CAA GCC GCG AGC AGT CA 
 
  Primers used in PCR2 
R11/R8C CTC GAG GTC CAG GTC CYG CC GAA TGG CGT TGG CAA ACC GG 
 
   
Reaction PCR2 and PCR1:  First cycle 3 minutes at 95 °c, followed by 40 cycles of  95 ° 30 
seconds, 60 degrees 30 seconds and 72 degrees 60 seconds, reaction was performed finally  at 72 
degrees 5 minutes. PCR2 similar program was applied the first step with the difference that the 
number of cycles from 40 cycles to 25 cycles decreased. PCR products were  analyzed using 
1.5% agarose electrophoresis and Ethidium bromide was observed under the final test results 
using SPSS-16 software and test and Pearson Chi-square analysis were compared. 
   
Results: 
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Presence of specific IgM antibodies of rubella in cord blood 
A total of 358 case studies, 348 were found to lack IgM antibodies against rubella virus and only 
2.8% were positive (Graph no.1). 
 
 
 
 
Graph no.1: frequency percentage of the results of IgM antibodies presence against rubella virus. 
  
 
 
 
 
Graph Number2: frequency percentage of the results of IgG antibodies against rubella virus. 
  
Comparison the results of rubella specific IgG and mother's with differed ages at delivery 
time 
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In this study, mothers are divided into two age groups: 
The first one in a mass vaccination at the age of vaccination were delivery have less than 29 
years old in  2003 and the other older than 29 years who did not receive vaccine at that time. 
Of 358 mothers, 254 (70.9%) were less than 29 years old and 104 (29.1%) more than 29 years 
old. By doing the statistical chi-square test of, there was a significant connection between mother 
age and being a negative rubella specific IgG(Chart 3).. 
 
 
 
Graph Number2: frequency percentage of the results of maternal age at delivery 
 
 
 
 From the number of 358 newborn babies, 190 (53.1%) were Male and 168 (46.9%) were 
Female. There was no significant relation for the gender. 
 
 
 
Analysis of RT-Nested PCR 
The samples that were negative in regard to IgG (16 samples) and also positive IgM samples (5 
samples) and some of randomly positive IgG  samples (10 samples which is statistically 
important) and were analyzed for the presence of virus genome via RT-Nested PCR. 
Also the sample of attenuated rubella vaccine samples was considered as a positive control. 
From the 31 samples, none of them were positive according to the presence of genome(Figure 1). 
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Figure 1: RT-Nested PCR results 
1: Ladder 100 bp, 2-6: Test,7: Neagtive control, 8: Positive control 
 
Discussion:  
 
Rubella epidemic cycle is one of 6- to 9-year intervals. In adults, the highest rate of exposure to 
this disease has been reported for women with congenital rubella. 
In fact, 80% of pregnant women in  the United States are safe against rubella and it is estimated 
that about 12500000 rubella cases occur over there. 
Congenital rubella has occurred in 30000 pregnancy cases with 10000 fetal deaths or abortion 
treatment and 20,000 CRS cases. This rate put 2 billion dollars financial costs on US government 
shoulders. According to the report of WHO, at least 236000 CRS has been seen in developing 
countries in non epidemic years and this range will be increased in least ten folds in epidemic 
ones. But there are limited reports of CRS in these countries. In addition, lacks of vaccination 
planning and epidemiological information are factors which can result in increasing exposure to 
rubella and CRS. 
In 2005, 32 million doses of vaccine was applied to people of 5-25 years old against measles and 
rubella in Iran. Diagnosis of rubella infection based on clinical observation can determine less 
then 50% of cases. In addition presence of IgG antibodies against rubella virus is not always 
indicative of epidemiological status of rubella infection. One of the objectives of this study was 
to survey congenital rubella infection in collected cord blood samples via ELISA method for 
identifying IgM antibodies against rubella virus. 
  
The results of IgM ELISA tests were positive. The results of a study done in Pasteur Institute 
with ELISA method in 1992-1997 identified presence of specific IgM antibodies to rubella in 
2.5% of pregnant women. Also, in this study about 94% of pregnant women had IgG antibodies 
via HI method. The results of this study are congruent with our ELISA test results. Another study 
was done in Bandar Abbas province in women of fertility ages in 2003 which 1% of the subjects 
had IgG Ab. Another purpose of this study was to survey the immunity-protective status of 
pregnant mothers and identifying specific IgG antibodies of rubella in cord blood samples of 
newborn babies which would show their immunity status. From 358 studies cases, 326 cases 
(91.1%) and 32 ones (8.9%) are respectively positive and negative. These results are confirmed 
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the results obtained in other studies that the range of immune protective of mothers has been 
reported to be 50-96.4%. 
Of 32 individuals with IgG-negative, 22 cases in a group were more than 29 years old (68.75%) 
and another 10 cases (31.25%) in the group have less than 29 years old. The levels of immunity 
in these two groups are 79% and 96% respectively. These differences were statistically 
significant. 
According to the results of this study it can be predicted that the immunity status of mothers who 
are not vaccinated is low therefore for prevention of CRS in this group of age it must be 
recommended to become vaccinated. At last it can be said that immunity status and respond to 
vaccination in society under survey is in an acceptable level. 
 Acknowledgements 
This essay would not have been possible unless the financial support of Iran University of 
Medical Sciences in the frame of research design that hereby the authors offer their regards and 
blessings to all of those who supported them during the completion of the project. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References: 
1. Mandell GL, Bennett G, Doline R. Principles and practice of infectious diseases. 6th ed. New York: 
Churchill Livingstone , 2005. 
2. Maton W.some account of a rash liable to be mistaken for scarlatina. Med Trans Coll  Physicians 
(Londen) 1815;5:149 – 165.  
3. Braunwald E, Fauci A, Kasper DL. Harrison's principles of internal medicine. 16th ed.New York: 
McGraw-Hill, 2005. 
4. Goldman L, Ausiello D. Cecil textbook of medicine. 22nd ed. Philadelphia: W.B Saunders, 2004. 
5. Robertson SE, Catts FT, Samuel R. Control of rubella and congenital rubella syndrome in developing 
countries. Bull World Health Organ 1997 ;75(1): 69-80. 
6. Yadavs G, Kumarj S. Sero prevalence of rubella in women of reproductive age. Indian J Pathol 
Microbial 1995 Apr; 38(2):139-42. 
7. Jacqur P , Chappuss S. Sero prevalence of rubella among women of child bearing age in Switzerland . 
Eur J Clin Microbiol Infect Dis 1995 Aug; 14(8): 6916. 
Canadian Journal on Medicine Vol. 2, No. 4, November 2011 
 
111 
 
8. Bamgboye AE, Afolabi KA, Esumoh F, Enweani IB. Prevalence of rubella antibody in pregnant women 
in Ibadan, Nigeria west. Afr J Med 2004 Jul-Sep; 23(3): 245-8. 
9. Sagornaga DD, Delgado M, Saenz FG. Frequency of antibodies against rubella virus in puerperium 
women. Gynecol Obstet Mex 2004 Sep; 72: 445-9. 
10. Gyorks TW, Beliveau C, Rohme E. High rubella seronegativity in daycare educators. Clin Invest Med 
2005 Jun; 28(3): 105-11. 
11. Karimi, Mohammad Mahdi. Summary of research on rubella serology in the final years of high school 
girls recently Hamadan. Hamadan: University of Medical Sciences, 137412.Tipples GA, et al. Evaluation 
of rubella IgM enzyme immunoassays. J Clin Virol 2004;30:233 – 238. 
13.Dimech W, et al. Evaluation of three immunoassays used for detection of anti-rubella virus 
immunologlobulin M antibodies. Clin Diagn Lab Immunol 2005;12:1104 – 1108. 
14.Thomas HI, Barrett E, Hesketh LM, Wynne A, Morgan-Capner P. Simultaneous IgM reactivity by EIA 
against more than one virus in measles, parvovirus B19 and rubella infection. J Clin Virol 1999;14:107 – 
118. 
15.Grangeot-Keros L, Enders G. Evaluation of a new enzyme immunoassay based on recombinant 
rubella virus-like particles for detection of immunoglobulin M antibodies to rubella virus. J Clin 
Microbiol 1997;35:398 – 401. 
16.Thomas HI, et al. Slow maturation of IgG1 avidity and persistence of specific IgM in congenital 
rubella implications for diagnosis and immunopathology. J Med Virol 1993;41:196 – 200.  
17.Best JM, et al. Interpretation of rubella serology in pregnancypitfalls and problems. BMJ 
2002;325:147 – 148. 
18.Cherry/Feigin-Textbook of pediatric infectious diseases-Third edition-Vol 2- Sanders-1992-USA-
1792-1810. 
19.Gerald Mandel/Bennett/Dollin-Principle and Practice of Infectious diseases-Fifth edition-Vol 2-
Churchil Living Stone-2000-USA.1708-1712. 
20.Herrmann KL: Rubella in the United States: toward a strategy for disease control and elimination. 
Epidemiol Infect 1991, 107:55-61. 
21.Preblud SR, Serdula MK, Frank JA Jr, Brandling-Bennett AD, Hinman AR: Rubella vaccination in the 
United States: a ten years review. Epidemiol Rev 1980, 2:171-9. 
22.World Health Organization (EPIGAG): Rubella and congenital rubella syndrome in developing 
countries. 14th Meeting 1991 . 
23.Miller CI: Rubella in the developing world. Epidemiol Infect 1991, 107(1):63-68. 
24. Northern JL, Downs MP: Hearing in Children Volume 2. 4th edition. Baltimore: Williams & Wilkins; 
1991:371. 
25. Zadeh Modarres Sh. Rubella infection during pregnancy and the level of immunity of pregnant women 
to rubella virus 
Canadian Journal on Medicine Vol. 2, No. 4, November 2011 
 
112 
 
  
26. Davoudian Parivashi, dale memory, praised Abdolreza Jahromi. The prevalence of antibodies against 
rubella in pregnant women aged in the city of Bandar Abbas  
 
27. Seyed Reza Majd Zadeh, Mohammad Efatpanah, Ali Moradi, Mohammad Javad Mohseni, oyster 
Qajar Spanlv, Z. Rajab Pour, Abbas Survey. Measles immunization coverage of public mobilization and 
rubella in south of Tehran Drmrkz Health 
 
 
